Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancers|June 24, 2022
Is High Expression of Claudin-7 in Advanced Colorectal Carcinoma Associated with a Poor Survival Rate? A Comparative Statistical and Artificial Intelligence StudyVictor Ianole, Mihai Danciu, Constantin Volovat, et al.
Oncotarget|September 11, 2020
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancerSimona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, et al.
Gels (Basel, Switzerland)|May 26, 2023
Theoretical and Experimental Aspects of Sodium Diclofenac Salt Release from Chitosan-Based Hydrogels and Possible ApplicationsLoredana Maria Himiniuc, Razvan Socolov, Irina Nica, et al.
Journal of Immunology Research|May 16, 2022
Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical CancerLoredana Maria Himiniuc, Bogdan Florin Toma, Razvan Popovici, et al.
BMJ Open|May 27, 2014
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort studySerban Negru, Eirini Papadopoulou, Angela Apessos, et al.
Journal of Personalized Medicine|October 23, 2021
Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing QuantificationCati Raluca Stolniceanu, Mihaela Moscalu, Doina Azoicai, et al.
Pharmaceutics|December 23, 2023
Theoretical-Experimental Approach of Chitosan/Quaternized Chitosan Nanofibers' Behavior in Wound Exudate MediaBianca-Iustina Andreica, Alexandru Anisiei, Manuela-Maria Iftime, et al.
The Lancet. Oncology|April 19, 2013
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trialFlorian Lordick, Yoon-Koo Kang, Hyun-Cheol Chung, et al.
Cancers|October 14, 2022
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AISimona-Ruxandra Volovat, Iolanda Augustin, Daniela Zob, et al.
Journal of Cardiovascular Pharmacology|February 23, 2013
A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxelPierre Maison-Blanche, Jan B Vermorken, Tuncay Goksel, et al.
Pageof 3